Objectives
After participating in this educational activity, attendees should be able to:
1|Describe the genetics and symptoms of Huntington’s Disease
2|Discuss of treatments currently available and under development
3|Recognize the importance of a multidisciplinary team and will learn strategies on how to implement a multidisciplinary team model in their own practice
Presenter(s):
Dr. Shakaib Khan M.D.
University of Connecticut Health Center
263 Farmington Ave, Farmington, Ct 06032
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Dr. Shakaib Khan M.D. | Speaker | No relevant relationships with ineligible companies to disclose | Antipsychotics for treatment of movements in HD |
Session date:
02/04/2026 - 9:00am to 10:00am EST
Location:
Zoom & In Person at Baystate Medical Center Lundy Board Room located in the Wesson Building
759 Chestnut Street
Springfield, MA
01199
United States
See map: Google Maps
Add to calendar:
- 1.00 AAPA Category 1 CME creditBaystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 IPCE Credit Hour(s)
Facebook
X
LinkedIn
Forward